Publication | Closed Access

The response to lovastatin treatment in patients with heterozygous familial hypercholesterolemia is modulated by apolipoprotein E polymorphism

Apolipoprotein E PolymorphismMetabolic SyndromeLipid DisorderHeterozygous Familial HypercholesterolemiaCardiovascular DiseaseHuman PolymorphismHyperlipidemiaLipoprotein MetabolismMedicineAtherosclerosisDyslipidemia